*Jubilant Organosys* swung to loss for the quarter ended December 2008. During the quarter, the company reported loss of Rs 211.60 million compared with a profit of Rs 851.00 million in the same quarter last year.
Net sales for the quarter rose 19.23% to Rs 5,896.10 million, while total income for the quarter rose 15.70% to Rs 5,910.20 million, when compared with the prior year period. The company reported loss of Rs 1.44 a share during the quarter compared with earnings of Rs 5.92 a share in prior year period. *Quarterly Results - Standalone (Rs in mn)* *As at* *Dec - 08* *Dec - 07* *%Change* *Net Sales* 5,896.10 4,945 19.23 *Net Profit* (211.60) 851 - *Basic EPS* (1.44) 5.92 - Interest cost increased 2.53 times to Rs 139.40 million while depreciation cost rose 33.45% to Rs 193.50 million over previous year period. Jubilant Organosys is an integrated pharmaceutical industry player with a wide range of products and services for global life sciences companies. --~--~---------~--~----~------------~-------~--~----~ You received this message because you are subscribed to the Google Groups "Kences1" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/kences1?hl=en -~----------~----~----~----~------~----~------~--~---
